Ananda Scientific announced that it received an FDA investigational new drug (IND) approval for a post-traumatic stress disorder (PTSD) treatment. The company will collaborate with the University of Nebraska Medical Center to conduct a clinical … [Read More...] about FDA approves IND for Ananda Scientific’s PTSD treatment with liquid structure delivery tech
Main Content
Sponsored Content
A new way to access scientific papers?
Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to find that leaving university also means leaving behind … [Read More...] about A new way to access scientific papers?
Paradigm Shift: How Noble Can Help Patients Reduce Errors During Biologic Initiation
Unmet Training Needs For Patients Using Self-Injectable Drug Therapies Comes At A High Cost A recent report published in Expert Opinion On Drug Delivery uncovered a startling paradigm regarding unmet … [Read More...] about Paradigm Shift: How Noble Can Help Patients Reduce Errors During Biologic Initiation
What needle should you use?
By Nathan Swihart, Social Media and Internet Sales Specialist Every professional should have comprehensive knowledge on the products they use on a daily basis. One of the widest-used and most … [Read More...] about What needle should you use?
Featured Posts
BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD … [Read More...] about BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
ApiJect picks up $111M investment from Royalty Pharma, Jefferies
Injection delivery system developer ApiJect announced today that it completed a private investment round worth $111 million. Royalty Pharma and Jefferies Financial Group led the investment round. Jefferies also acquired a revenue interest in … [Read More...] about ApiJect picks up $111M investment from Royalty Pharma, Jefferies
Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking … [Read More...] about Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Jabil launches Qfinity reusable auto-injector
Jabil's (NYSE:JBL) Jabil Healthcare division announced today that it launched its Qfinity auto-injector platform. St. Petersburg, Florida-based Jabil Healthcare designed the reusable Qfinity platform for simple subcutaneous drug … [Read More...] about Jabil launches Qfinity reusable auto-injector
Labcorp launches at-home collection device for diabetes risk testing
Labcorp (NYSE:LH) announced today that it launched an at-home collection kit that measures HbA1c from a small blood sample. Burlington, North Carolina-based Labcorp's first-of-its-kind diagnostic offering uses a collection device from Weavr Health … [Read More...] about Labcorp launches at-home collection device for diabetes risk testing
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A lot of talk around Dexcom (Nasdaq:DXCM) in the last couple of years has centered around its next-generation G7 continuous glucose monitor. The latest iteration of the company's CGM platform has already garnered CE mark this year and awaits FDA … [Read More...] about How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic's Resolute DES family, was designed to leverage the same stent platform as Resolute … [Read More...] about FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
Medtronic completes Intersect ENT acquisition
Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT). Fridley, Minnesota-based Medtronic announced in August 2021 that it would acquire all outstanding shares of the … [Read More...] about Medtronic completes Intersect ENT acquisition
Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally. Xience Skypoint has received FDA approval, the CE mark, and PMDA approval in Japan for the broadest expansion with the availability … [Read More...] about Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
Here’s what’s next for Insulet after the launch of Omnipod 5, CEO change
The future for Insulet (Nasdaq:PODD) has a different look than it did about a week ago. A massive shake-up at the executive level came on May 5 when Shacey Petrovic announced she would step down as president and CEO for personal … [Read More...] about Here’s what’s next for Insulet after the launch of Omnipod 5, CEO change
In case you missed it
- Senseonics beats The Street in Q1 following Eversense E3 launch
- ICU Medical beats The Street in Q1
- Shacey Petrovic to step down as Insulet CEO, ResMed exec Jim Hollingshead to take role
- Insulet posts Street-beating Q1 as Omnipod 5 rollout is ‘progressing very well’
- How DeepWell is developing video games as tools for treating medical conditions
- Tandem stock down after Q1 EPS miss
- Avanos rises as Q1 earnings match Wall Street projections
- Stevanato Group, Owen Mumford to collaborate on Aidaptus auto-injector
- Johnson & Johnson Vision wins Fast Company award for drug-eluting contact lens
- CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022
- Beta Bionics says iLet bionic pancreas reduces HbA1c and improves time in range for T1D
- Study shows fewer out-of-target blood glucose levels using Ascensia’s monitoring system
- Dexcom study shows strong accuracy for next-gen G7 CGM in pediatric T1D patients
- Stevanato Group, Bexson expand partnership for wearable drug delivery device
- Dexcom dips after hours on Q1 EPS miss, remains confident of U.S. G7 launch this year
Clinical Trials
FDA approves IND for Ananda Scientific’s PTSD treatment with liquid structure delivery tech
Ananda Scientific announced that it received an FDA investigational new drug (IND) approval for a post-traumatic stress disorder (PTSD) treatment. The company will collaborate with the University of Nebraska Medical Center to conduct a clinical trial, led by Dr. Mathew Rizzo, Reynolds Professor and Chair of the UNMC Department of Neurological Sciences and Chief Physician […]
Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking clinical trial results from the investigator-initiated, Medtronic-funded ROLEX (Revascularization Of LEft Main With Resolute onyX) registry. ROLEX, the largest real-world, multicenter prospective […]
CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022
All kinds of technologies were on display at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona last week. From continuous glucose monitoring (CGM) to automated insulin delivery, with plenty in between, a number of companies shared positive data for their diabetes offerings. Here are five of the biggest stories to come out […]
Beta Bionics says iLet bionic pancreas reduces HbA1c and improves time in range for T1D
Beta Bionics announced positive results from a pivotal trial of its iLet bionic pancreas for the delivery of insulin in diabetes patients. Concord, Massachusetts-based Beta Bionics designed the pocket-sized, wearable, investigational iLet device to autonomously dose insulin. Worn like an insulin pump, iLet users only enter bodyweight to initialize therapy without the need for insulin […]
Study shows fewer out-of-target blood glucose levels using Ascensia’s monitoring system
Ascensia Diabetes Care announced today that a new study demonstrates reduced out-of-target blood glucose ranges with its Contour system. The company, which distributes Senseonics’ Eversense continuous glucose monitor (CGM), develops the Contour blood glucose monitoring (BGM) systems and the Contour diabetes app (CDA) for people with diabetes who are managing their blood glucose levels. According […]
